Sam Chun Dang Pharm Signs U.S. Licensing Deal for Oral Obesity Drug; $150 Million Milestone
U.S. Licensing Rights for Rybelsus and Wegovy Oral Generics
Quarterly Settlement of Net Profits... 90% Allocated to Sam Chun Dang Pharm
Sam Chun Dang Pharm announced on March 30 that it has signed a U.S. licensing agreement with its American partner for the generics of the oral diabetes medication "Rybelsus" and the oral obesity treatment "Wegovy Oral" (active ingredient: semaglutide).
The total milestone amount is $100 million (approximately 150.8 billion won).
Net profits generated from product sales will be settled and distributed on a quarterly basis. For 10 years from the first day of sale, Sam Chun Dang Pharm will receive 90% and the partner company 10%. If the partner company fails to achieve 50% of the expected sales for two consecutive years, Sam Chun Dang Pharm has the right to terminate the agreement or change the contract terms.
The company cited its "SNAC-Free" technology as the background for this agreement.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Wegovy's developer, Novo Nordisk, has registered a formulation patent related to the absorption enhancer SNAC through 2039. However, Sam Chun Dang Pharm explained that it avoided patent infringement by developing an alternative substance that maximizes absorption without SNAC, utilizing its proprietary "S-PASS" platform.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.